1. Home
  2. BDTX vs FCNCP Comparison

BDTX vs FCNCP Comparison

Compare BDTX & FCNCP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BDTX
  • FCNCP
  • Stock Information
  • Founded
  • BDTX 2014
  • FCNCP N/A
  • Country
  • BDTX United States
  • FCNCP United States
  • Employees
  • BDTX N/A
  • FCNCP 17475
  • Industry
  • BDTX Biotechnology: Biological Products (No Diagnostic Substances)
  • FCNCP Major Banks
  • Sector
  • BDTX Health Care
  • FCNCP Finance
  • Exchange
  • BDTX Nasdaq
  • FCNCP Nasdaq
  • Market Cap
  • BDTX 181.4M
  • FCNCP N/A
  • IPO Year
  • BDTX 2020
  • FCNCP N/A
  • Fundamental
  • Price
  • BDTX $3.16
  • FCNCP $21.76
  • Analyst Decision
  • BDTX Strong Buy
  • FCNCP
  • Analyst Count
  • BDTX 6
  • FCNCP 0
  • Target Price
  • BDTX $12.50
  • FCNCP N/A
  • AVG Volume (30 Days)
  • BDTX 840.0K
  • FCNCP N/A
  • Earning Date
  • BDTX 11-04-2025
  • FCNCP N/A
  • Dividend Yield
  • BDTX N/A
  • FCNCP N/A
  • EPS Growth
  • BDTX N/A
  • FCNCP N/A
  • EPS
  • BDTX 0.25
  • FCNCP N/A
  • Revenue
  • BDTX $70,000,000.00
  • FCNCP N/A
  • Revenue This Year
  • BDTX N/A
  • FCNCP N/A
  • Revenue Next Year
  • BDTX N/A
  • FCNCP N/A
  • P/E Ratio
  • BDTX $12.78
  • FCNCP N/A
  • Revenue Growth
  • BDTX N/A
  • FCNCP N/A
  • 52 Week Low
  • BDTX $1.20
  • FCNCP N/A
  • 52 Week High
  • BDTX $6.23
  • FCNCP N/A
  • Technical
  • Relative Strength Index (RSI)
  • BDTX 58.90
  • FCNCP 48.56
  • Support Level
  • BDTX $3.13
  • FCNCP $21.56
  • Resistance Level
  • BDTX $3.43
  • FCNCP $21.94
  • Average True Range (ATR)
  • BDTX 0.18
  • FCNCP 0.29
  • MACD
  • BDTX 0.02
  • FCNCP -0.05
  • Stochastic Oscillator
  • BDTX 63.51
  • FCNCP 47.50

About BDTX Black Diamond Therapeutics Inc.

Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.

About FCNCP First Citizens BancShares Inc.

First Citizens BancShares Inc is the bank holding company of First Citizens Bank and Trust Company. The company's segments include the General Bank, the Commercial Bank, SVB Commercial, and Rail. The General Bank segment delivers products and services to consumers and businesses through its extensive network of branches and various digital channels. The Commercial Bank segment provides financial services, including lending, leasing, and advisory, to small and mid-market businesses across various industries. The SVB Commercial provides financial services to innovators, investors, and venture firms. The Rail segment provides tailored leasing and financing for railcars and locomotives across North America. It generates the majority of its revenue from the General Banking segment.

Share on Social Networks: